- Home
- MIRM vs LTH Comparison
MIRM vs LTH Comparison
Compare MIRM & LTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIRM | LTH |
|---|---|---|
| Founded | 2018 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 5.8B |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MIRM | LTH |
|---|---|---|
| Price | $96.17 | $27.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 7 |
| Target Price | ★ $115.33 | $40.57 |
| AVG Volume (30 Days) | 833.2K | ★ 2.7M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 74.59 | ★ 124.32 |
| EPS | N/A | ★ 1.66 |
| Revenue | $19,138,000.00 | ★ $2,995,255,000.00 |
| Revenue This Year | $26.22 | $11.98 |
| Revenue Next Year | $21.77 | $11.45 |
| P/E Ratio | ★ N/A | $16.72 |
| Revenue Growth | N/A | ★ 14.28 |
| 52 Week Low | $36.88 | $24.14 |
| 52 Week High | $109.28 | $34.99 |
Technical Indicators
Market Signals| Indicator | MIRM | LTH |
|---|---|---|
| Relative Strength Index (RSI) | 57.29 | 56.98 |
| Support Level | $85.35 | $25.00 |
| Resistance Level | $96.65 | $28.36 |
| Average True Range (ATR) | 4.11 | 0.86 |
| MACD | 0.90 | 0.22 |
| Stochastic Oscillator | 90.61 | 98.31 |
Price Performance
Historical ComparisonAbout MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
About LTH Life Time Group Holdings Inc.
Life Time Group Holdings Inc is a lifestyle and leisure brand offering health, fitness, and wellness experiences to a community. It is engaged in designing, building, and operating distinctive and large, multi-use sports and athletic, professional fitness, family recreation, and spa centers in a resort-like environment, principally in residential locations of metropolitan areas in the United States and Canada.